The GLP-1 Ripple Effect: Why Eating Less Is Changing What People Buy

In 30 seconds

• GLP-1 medicines are beginning to change how people spend as well as how they eat.
• UK research suggests users are spending less on snacks, confectionery and sugary drinks while spending more on fresh food, protein, supplements, fitness and clothing.
• PwC found that 40% of UK GLP-1 users reported spending more on clothing, 30% more on fitness and 40% more on vitamins and supplements.
• Changing body size can create an obvious expense: old clothes no longer fit.
• Some consumers appear to shift money towards activewear, beauty, skincare, personal care and fitness technology.
• The story is not simply “people save money on food”. Private GLP-1 treatment itself can be expensive.
• Not everyone follows the same pattern, and survey data can show associations without proving that the medicine caused every purchasing decision.
• Retailers are already adapting products, pack sizes, clothing ranges and marketing to this emerging market.
• The GLP-1 revolution may therefore become an economic and cultural story as well as a medical one.

What is “retail reallocation”?

The phrase sounds like something from an economics textbook.

The idea is actually very simple.

Imagine somebody previously spent £100 across:

• Takeaway meals
• Alcohol
• Snacks
• Confectionery
• Larger supermarket shops

Then their appetite changes dramatically.

They no longer want the same quantity of food.

Some of that £100 may simply be saved.

Some may pay for their medication.

But some may move somewhere else:

• Better-quality food
• Protein-rich products
• Vitamins and supplements
• Smaller clothes
• Gym membership
• Trainers
• Fitness trackers
• Skincare
• Haircare
• Beauty treatments
• Holidays or leisure
• Savings

Are people really spending less on food?

Increasingly, the answer appears to be yes — although the size of the effect varies between studies.

Research published in Britain during 2026 has begun to put numbers around it.

PwC Strategy& surveyed more than 2,300 UK adults and found striking differences in reported spending among GLP-1 users.

Among those surveyed:

• 70% said they spent less on snacks and confectionery
• 60% spent less on sugary drinks
• 60% spent more on fresh food
• 54% spent more on high-protein options

Hundreds of pounds leaving the grocery basket

Research from Worldpanel by Numerator reported in June 2026 examined more than 11,000 British households.

Households containing a GLP-1 user were estimated to have spent about £418 less on groceries over a year than comparable households.

Users also reported fewer cravings and less of what is sometimes called “food noise” — persistent thoughts about eating.

That potentially affects more than calories. If somebody walks past the biscuit aisle without particularly wanting biscuits, the supermarket has lost an impulse purchase.

What is disappearing from the shopping basket?

The categories most consistently under pressure appear to be the ones you might expect:

• Confectionery
• Crisps
• Salty snacks
• Sugary drinks
• Alcohol
• Some restaurant and takeaway spending
• Larger portions
• Impulse foods

PwC's US research found that 61% of current GLP-1 users said they were buying fewer sweet treats and 56% were purchasing fewer salty snacks.

This matters enormously to food manufacturers because many highly profitable products are built around:

• Craving
• Convenience
• Indulgence
• Repeat snacking
• Large portion sizes

GLP-1 medicines interfere with some of those behavioural drivers. That does not mean the snack industry is about to disappear, but companies are watching closely.

What replaces the old food basket?

This is where the story becomes more interesting.

Consumers do not simply stop eating.

PwC found increases in purchases of foods such as:

• Fresh produce
• Fresh protein
• Packaged protein
• Greek yoghurt
• Nutrition bars

Food manufacturers are already considering products designed for people who have much smaller appetites but still need adequate nutrition.

Protein, fibre and micronutrient density become more important.

This is one reason food companies are experimenting with smaller portions, high-protein foods, nutrient-dense meals and products aimed specifically at people using GLP-1 medicines.

Then comes the new-clothes problem

There is one purchase that can become unavoidable after substantial weight loss.

Someone who drops several clothing sizes may need:

• Trousers
• Underwear
• Work clothes
• Coats
• Dresses
• Suits
• Sportswear

Sometimes more than once during the weight-loss journey.

PwC's 2026 US research found that 73% of current GLP-1 users reported a meaningful change in clothing size.

Apparel spending among users increased by about 9.9% after six to eight months of treatment in its analysis.

Circana has even coined a phrase for the phenomenon:

the “Body Transformation Economy”.

Its US survey found that 55% of active GLP-1 users had already purchased new clothing or footwear.

Why people may not buy the entire wardrobe immediately

Someone losing weight may think:

People can move through a succession of temporary sizes.

That may encourage:

• Cheaper transitional clothing
• Second-hand shopping
• Clothing alterations
• Flexible fits
• Delaying expensive purchases
• Buying only essentials until weight stabilises

Once the person's size becomes more stable, spending may rise again.

Could GLP-1 medicines bring people back into physical shops?

An unexpected trend has appeared.

Buying clothes online is easy when you know your usual size.

But after substantial weight loss, you may have no idea what fits anymore.

Reuters reported in August 2026 that many GLP-1 users were returning to physical shops because they wanted to try clothes on.

Some retailers are responding with:

• Better fitting services
• Personal styling
• Easier alterations
• Flexible exchange policies

A medicine developed for metabolic disease may therefore indirectly help revive part of the in-store clothes-shopping experience.

Fitness spending is changing too

Weight loss can change someone's relationship with exercise.

PwC's UK research found that 30% of GLP-1 users reported spending more on fitness.

Its US study found that 36% of current users had increased activities such as:

• Walking
• Running
• Cycling
• Swimming

Around 15% were using wearable technology to help manage their health while taking the medication.

These can include:

• Smartwatches
• Fitness bands
• Heart-rate tracking
• Activity tracking
• Sleep monitoring
• Calorie or nutrition apps

The muscle question changes the fitness conversation

Substantial weight loss does not consist entirely of body fat.

Some lean tissue can also be lost.

That makes preserving muscle increasingly important during significant weight reduction.

This can increase interest in:

• Strength training
• Resistance exercise
• Adequate protein
• Recovery
• Muscle-health products
• Fitness coaching

Retail data suggest that GLP-1 users are showing disproportionate interest in products carrying muscle-health claims. That does not prove those products are necessary, but it shows where consumer attention is moving.

Beauty and personal care enter the picture

Then there is the mirror.

Large changes in body weight can change:

• Facial appearance
• Body shape
• Skin appearance
• Clothing style
• Hair and beauty routines
• Self-confidence

Some people simply become more interested in appearance after losing weight.

Others may seek products because rapid weight change raises new concerns about:

• Loose skin
• Dry skin
• Facial volume
• Hair
• Body care

BCG's 2026 consumer research found that part of the money redirected away from food was moving towards categories including:

• Beauty
• Personal care
• Aesthetics
• Apparel
• Fitness
• Supplements

Even major food companies are moving into the beauty-and-muscle conversation

In August 2026, Reuters reported that Nestlé was developing more products specifically aimed at people taking GLP-1 medicines.

Its work includes products focusing on:

• Protein
• Muscle preservation
• Collagen
• Nutritional support during reduced food intake

That does not automatically mean specialised products are necessary.

Ordinary food can provide excellent protein and nutrients.

But it tells us something important about where large consumer companies believe the market is moving.

Vitamins and supplements are another winner

PwC found that 40% of UK GLP-1 users reported spending more on vitamins and supplements.

That is understandable.

When somebody suddenly eats much less, they may worry about whether they are getting enough:

• Protein
• Vitamins
• Minerals
• Fibre
• Essential fats

But this is also an area where marketing can run ahead of evidence.

A smaller appetite does not automatically mean somebody needs a cupboard full of supplements.

Do GLP-1 users actually save money?

Sometimes.

But this question is more complicated than headlines suggest.

Lower grocery spending can generate meaningful savings.

However, many UK users obtain GLP-1 medicines privately.

The medication itself may cost substantially more than the amount saved on food.

Income matters too.

A high-income user may redirect spending towards:

• Better clothes
• Gym membership
• Premium food
• Beauty treatments
• Travel

Someone on a tight budget may simply have less disposable money after paying for the medication. There is no single GLP-1 consumer.

One-third saved, one-third paid for treatment, one-third went elsewhere

BCG's 2026 US research offers a useful way to visualise the effect.

Among users surveyed, money freed up from food was expected to be divided approximately into thirds:

• One part towards savings
• One part towards the cost of treatment
• One part redirected into other categories

Those other categories included:

• Supplements
• Beauty and personal care
• Clothing
• Fitness
• Aesthetics

That is probably a better mental model than simply saying: “GLP-1 users buy less food.”

Why businesses are paying so much attention

If GLP-1 use remained rare, none of this would matter very much to retailers.

But adoption is rising rapidly.

PwC estimated in June 2026 that around 5% of UK adults were currently using GLP-1 medication, while around 9% had used it at some point.

Its survey suggested uptake could increase substantially now that oral weight-management GLP-1 medicines are arriving.

If millions more people eventually use these medicines, seemingly small individual changes become enormous market shifts.

That is why supermarkets, fashion retailers, gyms, supplement companies, restaurants and beauty businesses are paying attention.

There is also an uncomfortable clothing-size question

Not every consequence of this trend is straightforwardly positive.

Some fashion brands are reportedly reducing their plus-size ranges as retailers anticipate greater demand for smaller clothing sizes.

That creates a risk.

GLP-1 use is increasing, but millions of people will continue to need larger sizes.

Retailers can easily overinterpret a trend and leave existing customers with fewer choices.

Does the behaviour continue when people stop GLP-1 medicines?

Perhaps some of it does.

This is one of the most interesting areas of emerging research.

We already know from clinical trials that significant weight regain can occur after GLP-1 treatment stops.

Food cravings can also return.

Yet purchasing habits do not necessarily reset immediately.

PwC reported that more than 80% of former UK users said they had maintained at least some of the dietary or grocery changes they developed while taking treatment.

BCG similarly found that some behaviours involving fitness, supplements and personal care appeared more durable than the initial changes in appetite.

If that proves true over longer periods, GLP-1 medicines may influence consumer behaviour even after an individual prescription ends.

What is new right now? — August 2026

This story is developing almost week by week.

That makes it an ideal living page.

We will update this page as the GLP-1 economy, consumer behaviour and supporting research continue to develop.

What we know — and what we should not assume

What we know

Current consumer research suggests that many GLP-1 users:

• Eat less
• Buy fewer snacks and sugary drinks
• Buy more fresh foods and protein
• Spend more on supplements
• Change clothing size
• Spend more on apparel
• Increase some forms of exercise
• Buy fitness and wellness products
• Redirect some spending towards beauty and personal care

What we should not assume

These surveys do not prove that:

• Every GLP-1 user behaves this way
• Every spending change was directly caused by the medicine
• Every user saves money
• Weight loss automatically increases confidence
• Everyone needs supplements
• Every user will maintain the same weight
• Retailers should abandon customers who still require larger sizes

What does this mean for the person taking a GLP-1?

There is actually a useful health lesson hiding inside the economics.

When appetite falls, priorities change.

If you are eating considerably less, think carefully about what remains.

Ask:

• Am I getting enough protein?
• Am I eating vegetables and fruit?
• Am I getting adequate fibre?
• Is my diet still varied?
• Am I strength training where appropriate?
• Am I buying supplements because I need them — or because advertising tells me that I do?
• Am I spending money solving a genuine problem?

How we can help

If a GLP-1 medicine has substantially changed your appetite, the nutritional challenge can also change.

The question is no longer necessarily how to eat less.

It may be how to get enough nutrition from less food.

The purpose is not to sell more things to somebody because they are eating less. It is to help make sure that less food still means good nutrition.

Research record

First published: 22 August 2026
Last reviewed: 22 August 2026
Latest evidence update: 22 August 2026

Key sources

• PwC Strategy& UK. GLP-1 medicines are set to reshape UK consumer spending. June 2026.
• PwC US. The end of more: How GLP-1 users shop, eat, and seek support. 2026.
• Boston Consulting Group. The Unexpected Ways GLP-1s Are Transforming Consumer Behavior. August 2026.
• Circana. GLP-1 Medication Usage is Impacting the U.S. Apparel Industry. March 2026.
• Worldpanel by Numerator. Consumer research on UK GLP-1 household grocery spending, reported June 2026.
• Reuters. For GLP-1 users, the in-store clothes shopping trip is back. August 2026.
• Reuters. Reporting on Nestlé developing products aimed at GLP-1 users, including protein, muscle-preservation and collagen-focused products. August 2026.
• Treated UK. What trends have GLP-1s started? 2026.